It is an aggressive tumor typically characterized by a fusion of the Ewing sarcoma breakpoint region 1 (EWSR1) with an erythroblast transformation specific (ETS) transcription factor gene, most frequently (>95%) the friend leukemia virus integration 1 (FLI1) gene [4,5]. The gene discussed is FLI1; the disease is neoplasm.